Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIGRE: Tacrolimus Regimens in Marginal Renal Transplant
NCT00321113Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2004
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus + Wuzhi capsule in kidney transplantation (2 arms), sponsored by Astellas Pharma. Primary endpoint: Calculated Creatinine Clearance at 6 months. Started Sep 2004; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00321113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321113.